Lyme Disease-European Perspective

Infectious Disease Clinics of North America

Volumn 22, Issue 2, 2008, Pages 327-339

  Stanek, Gerold ^a   Strle, Franc ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME AXETIL; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G; PENICILLIN V;

ACRODERMATITIS CHRONICA ATROPHICANS; ANTIBIOTIC THERAPY; ARTHRITIS; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CARDITIS; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; EUROPE; HUMAN; IMMUNOPROPHYLAXIS; LYME DISEASE; LYMPHOCYTOMA; NEURITIS; NONHUMAN; NORTH AMERICA; POLYMERASE CHAIN REACTION; RADICULAR PAIN; REVIEW; SEROLOGY; SKIN MANIFESTATION; TREATMENT DURATION;

ANIMALS; ERYTHEMA CHRONICUM MIGRANS; EUROPE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LYME DISEASE; LYME NEUROBORRELIOSIS; PSEUDOLYMPHOMA;

EID: 42949156146     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2008.01.001     Document Type: Review

References (67)

1. Stanek G., Wewalka G., Groh V., et al. Differences between Lyme disease and European arthropod-borne Borrelia infections. Lancet 1 8425 (1985) 401
2. Stanek G., and Strle F. Lyme borreliosis. Lancet 362 9396 (2003) 1639-1647
3. Buchwald A. Ein Fall von diffuser idiopathischer Haut-Atrophie. Archiv für Dermatologie und Syphilis 10 (1883) 419-420
4. Herxheimer K., and Hartmann K. Über Acrodermatitis chronica atrophicans. Archiv für Dermatologie und Syphilis 61 (1902) 57-76
5. Afzelius A. Verhandlungen der Dermatologischen Gesellschaft zu Stockholm, 28. Oct 1909. Archiv für Dermatologie und Syphilis 101 (1910) 404
6. Lipschütz B. Über eine seltene Erythemform (Erythema chronicum migrans). Archiv für Dermatologie und Syphilis 118 (1913) 349-356
7. Lipschütz B. Weiterer Beitrag zur Kenntnis des "Erythema chronicum migrans.". Archiv für Dermatologie und Syphilis 143 (1923) 365-374
8. Bäfverstedt B. Über Lymphadenosis benigna cutis. Archiv Dermatologie & Venereologie (Stockholm) 24 (1943) 1-202
9. Burckhardt J.L. Zur Frage der Follikel- und Keimzentrenbildung in der Haut. Frankfurter Zeitschrift für Pathologie 6 (1911) 352-359
10. Garin C., and Bujadoux C.H. Paralysie par les tiques. J Med Lyon 71 (1922) 765-767
11. Hellerström S. Erythema chronicum migrans Afzelii. Archiv Dermatologie & Venereologie (Stockholm) 11 (1930) 315-321
12. Bannwarth A. Zur Klinik und Pathogenese der "chronisch lymphozytären Meningitis.". Archiv für Psychiatrie und Nervenkrankheiten 117 (1941) 161-185
13. Thyresson N. The penicillin treatment of acrodermatitis chronica atrophicans (Herxheimer). Acta Derm Venereol 29 (1949) 572-621
14. Hauser W. Zur Kenntnis der Akrodermatitis chronica atrophicans. Archiv für Dermatologie und Syphilis 199 (1955) 350-393
15. Hopf H.C. Acrodermatitis chronica atrophicans (Herxheimer) und Nervensystem. In: Monographien aus dem Gesamtgebiete der Neurologie und Psychiatrie. vol. 114 (1966), Springer, New York
16. Hollström E. Penicillin treatment of erythema chronicum migrans Afzelius. Archiv Dermatologie & Venereologie (Stockholm) 38 (1958) 285-289
17. Schaltenbrand G. Durch Arthropoden übertragene Erkrankung der Haut und des Nervensystems. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 72 (1967) 975-1006
18. Hörstrup P., and Ackermann R. Durch Zecken übertragene Meningopolyneuritis (Garin-Bujadouix, Bannwarth). Fortschritte der Neurologie und Psychiatrie 41 (1973) 583-606
19. Weber K. Erythema chronicum migrans meningitis-a bacterial infectious disease?. Munch Med Wochenschr 116 45 (1974) 1993-1998
20. Steere A.C., Malawista S.E., Snydman D.R., et al. Lyme arthritis. An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 20 (1977) 7-17
21. Steere A.C., and Malawista S.E. Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini. Ann Intern Med 91 (1979) 730-733
22. Steere A.C., Malawista S.E., Newman J.H., et al. Antibiotic therapy in Lyme disease. Ann Intern Med 93 1 (1980) 1-8
23. Burgdorfer W., Barbour A.G., Hayes S.F., et al. Lyme disease-a tick-borne spirochetosis?. Science 216 (1982) 1317-1319
24. Barbour A.G. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 57 4 (1984) 521-525
25. Benach J.L., Bosler E.M., Hanrahan J.P., et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 308 13 (1983) 740-742
26. Steere A.C., Grodzicki R.L., Kornblatt A.N., et al. The spirochetal etiology of Lyme disease. N Engl J Med 308 (1983) 733-740
27. Preac-Mursic V., Schierz G., Pfister H.W., et al. Isolation of a spirochete from cerebrospinal fluid of a patient with meningoradiculitis Bannwarth. Munch Med Wochenschr 126 (1984) 275-276
28. Asbrink E., and Hovmark A. Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Acta Pathol Microbiol Immunol Scand [B] 93 2 (1985) 161-163
29. Stanek G., Wewalka G., Groh V., et al. Isolation of spirochetes from the skin of patients with erythema chronicum migrans in Austria. Zentralbl Bakteriol Mikrobiol Hyg [A] 260 1 (1985) 88-90
30. Johnson R.C., Schmid G.P., Hyde F.W., et al. Borrelia burgdorferi sp. nov. etiologic agent of Lyme disease. Int J Syst Bacteriol 34 (1984) 496-497
31. Wilske B., Preac-Mursic V., Göbel U.B., et al. An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J Clin Microbiol 31 (1993) 340-350
32. Baranton G., Postic D., Saint Girons I., et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42 (1992) 378-383
33. In: Stanek G., Flamm H., Barbour A.G., et al. (Eds). Lyme borreliosis (1986), Gustav Fischer Verlag, Stuttgart (Germany)
34. Le Fleche A., Postic D., Girardet K., et al. Characterization of Borrelia lusitaniae sp. nov. by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol 47 4 (1997) 921-925
35. Wang G., van Dam A.P., Le Fleche A., et al. Genetic and phenotypic analysis of Borrelia valaisiana sp. nov. (Borrelia genomic groups VS116 and M19). Int J Syst Bacteriol 47 4 (1997) 926-932
36. Postic D., Ras N.M., Lane R.S., et al. Expanded diversity among Californian borrelia isolates and description of Borrelia bissettii sp. nov. (formerly Borrelia group DN127). J Clin Microbiol 36 12 (1998) 3497-3504
37. Masuzawa T. Terrestrial distribution of the Lyme borreliosis agent Borrelia burgdorferi sensu lato in East Asia. Jpn J Infect Dis 57 (2004) 229-235
38. Richter D., Postic D., Sertour N., et al. Delineation of Borrelia burgdorferi sensu lato species by multilocus sequence analysis and confirmation of the delineation of Borrelia spielmanii sp. nov. Int J Syst Evol Microbiol 56 4 (2006) 873-881
39. Gray J.S., and Stanek G. Risk assessment in Lyme borreliosis. Zentralbl Bakteriol 287 3 (1998) 175-176
40. Wormser G.P. Hematogenous dissemination in early Lyme disease. Wien Klin Wochenschr 118 21-22 (2006) 634-637
41. Maraspin V., Ruzić-Sabljić E., Cimperman J., et al. Isolation of Borrelia burgdorferi sensu lato from blood of patients with erythema migrans. Infection 29 2 (2001) 65-70
42. Arnez M., Ruzić-Sabljić E., Ahcan J., et al. Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans. Pediatr Infect Dis J 20 3 (2001) 251-255
43. Huppertz H.I., Karch H., Suschke H.J., et al. Lyme arthritis in European children and adolescents. Arthritis Rheum 38 (1995) 361-368
44. Stanek G., O'Connell S., Cimmino M., et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 108 23 (1996) 741-747
45. Strle F., Maraspin V., Furlan-Lotric S., et al. Epidemiological study of a cohort of adult patients with erythema migrans registered in Slovenia in 1993. Eur J Epidemiol 12 5 (1996) 503-507
46. Strle F., Nelson J.A., Ruzic-Sabljic E., et al. European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans. Clin Infect Dis 23 1 (1996) 61-65
47. Ruzić-Sabljić E., Maraspin V., Lotric-Furlan S., et al. Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia. Wien Klin Wochenschr 114 13-14 (2002) 544-550
48. Strle F., Nadelman R.B., Cimperman J., et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 130 1 (1999) 32-36
49. Strle F., Pleterski-Rigler D., Stanek G., et al. Solitary borrelial lymphocytoma: report of 36 cases. Infection 20 4 (1992) 201-206
50. Picken R.N., Strle F., Picken M.M., et al. Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrophicans lesions. J Invest Dermatol 110 3 (1998) 211-214
51. Kristoferitsch W., Sluga E., Graf M., et al. Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features. Ann N Y Acad Sci 539 (1988) 35-45
52. Hovmark A., Asbrink E., and Olsson I. Joint and bone involvement in Swedish patients with Ixodes ricinus-borne Borrelia infection. Zentralbl Bakteriol Mikrobiol Hyg [A] 263 1-2 (1986) 275-284
53. Kristoferitsch W. Lyme borreliosis in Europe. Neurologic disorders. Rheum Dis Clin North Am 15 4 (1989) 767-774
54. Christen H.J., Hanefeld F., Eiffert H., et al. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl 386 (1993) 1-75
55. Strle F., Ruzić-Sabljić E., Cimperman J., et al. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 43 6 (2006) 704-710
56. Ackermann R., Rehse-Küpper B., Gollmer E., et al. Chronic neurologic manifestations of erythema migrans borreliosis. Ann N Y Acad Sci 539 (1988) 16-23
57. Wokke J.H., de Koning J., Stanek G., et al. Chronic muscle weakness caused by Borrelia burgdorferi meningoradiculitis. Ann Neurol 22 3 (1987) 389-392
58. Priem S., Munkelt K., Franz J.K., et al. Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey. Z Rheumatol 62 5 (2003) 450-458
59. Herzer P. Joint manifestations of Lyme borreliosis in Europe. Scand J Infect Dis Suppl 77 (1991) 55-63
60. Eiffert H., Karsten A., Thomssen R., et al. Characterization of Borrelia burgdorferi strains in Lyme arthritis. Scand J Infect Dis 30 (1998) 265-268
61. Marlovits S., Khanakah G., Striessnig G., et al. Emergence of Lyme arthritis after autologous chondrocyte transplantation. Arthritis Rheum 50 1 (2004) 259-264
62. Strle F. Principles of the diagnosis and antibiotic treatment of Lyme borreliosis. Wien Klin Wochenschr 111 22-23 (1999) 911-915
63. Robertson J., Guy E., Andrews N., et al. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 38 6 (2000) 2097-2102
64. Nadelman R.B., and Wormser G.P. Lyme borreliosis. Lancet 352 9127 (1998) 557-565
65. Picken M.M., Picken R.N., Han D., et al. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis. Mol Pathol 50 4 (1997) 186-193
66. Steere A.C. Lyme disease. N Engl J Med 345 2 (2001) 115-125
67. Kristoferitsch W., Baumhackl U., Sluga E., et al. High-dose penicillin therapy in meningopolyneuritis Garin-Bujadoux-Bannwarth. Clinical and cerebrospinal fluid data. Zentralbl Bakteriol Mikrobiol Hyg [A] 263 3 (1987) 357-364